Investors had grown weary that the massive run-up in spending on AI hardware might not be sustainable, stoking fears of a bubble building in the sector.
Investing.com -- UniQure N.V. (NASDAQ:QURE) shares fell 22% Thursday after FDA Commissioner Marty Makary made comments about a rare disease drug trial that appeared to reference the company’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results